In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hang Lung Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:10 - Analysts future estimates and past financials data (HKD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	11,924	2,017	3,814	3,814	N/A
3/31/2024	11,466	2,414	3,918	3,918	N/A
12/31/2023	11,008	2,811	4,022	4,022	N/A
9/30/2023	10,941	2,886	4,394	4,394	N/A
6/30/2023	10,874	2,961	4,766	4,766	N/A
3/31/2023	10,937	2,840	4,605	4,605	N/A
12/31/2022	11,000	2,718	4,443	4,443	N/A
9/30/2022	11,191	2,619	4,665	4,665	N/A
6/30/2022	11,382	2,520	4,887	4,887	N/A
3/31/2022	11,144	2,555	3,965	3,965	N/A
12/31/2021	10,905	2,589	3,043	3,043	N/A
9/30/2021	10,547	2,076	2,668	2,668	N/A
6/30/2021	10,189	1,562	2,292	2,292	N/A
3/31/2021	9,712	11	3,027	3,027	N/A
12/31/2020	9,235	-1,541	3,761	3,761	N/A
9/30/2020	9,257	-14	4,380	4,380	N/A
6/30/2020	9,279	1,512	4,998	4,998	N/A
3/31/2020	9,449	4,164	5,348	5,348	N/A
12/31/2019	9,618	6,816	5,698	5,698	N/A
9/30/2019	9,484	6,387	5,353	5,353	N/A
6/30/2019	9,349	5,957	5,007	5,007	N/A
3/31/2019	9,900	5,621	5,556	5,556	N/A
12/31/2018	10,450	5,285	6,104	6,104	N/A
9/30/2018	10,729	5,620	5,942	5,942	N/A
6/30/2018	11,007	5,955	5,780	5,780	N/A
3/31/2018	11,501	5,635	N/A	7,309	N/A
12/31/2017	11,995	5,314	N/A	8,837	N/A
9/30/2017	12,887	4,817	N/A	9,666	N/A
6/30/2017	13,778	4,319	N/A	10,495	N/A
3/31/2017	13,778	4,016	N/A	8,762	N/A
12/31/2016	13,777	3,713	N/A	7,028	N/A
9/30/2016	12,625	3,468	N/A	6,696	N/A
6/30/2016	11,473	3,222	N/A	6,364	N/A
3/31/2016	10,629	3,217	N/A	6,182	N/A
12/31/2015	9,784	3,211	N/A	5,999	N/A
9/30/2015	13,905	4,878	N/A	9,904	N/A
6/30/2015	18,025	6,544	N/A	13,809	N/A
3/31/2015	17,993	6,685	N/A	14,632	N/A
12/31/2014	17,961	6,825	N/A	15,454	N/A
9/30/2014	14,654	5,838	N/A	11,493	N/A
6/30/2014	11,346	4,851	N/A	7,531	N/A
3/31/2014	10,756	4,704	N/A	6,352	N/A
12/31/2013	10,165	4,557	N/A	5,172	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 10's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 10's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 10's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 10's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 10's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 10's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 22:10
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hang Lung Group Limited is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Andrew Lawrence	Barclays
Manfred Ho	BOCI Research Ltd.
Cusson Leung	Credit Suisse

Hang Lung Group Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Investor sentiment improves as stock rises 17%

Investors Can Find Comfort In Hang Lung Group's (HKG:10) Earnings Quality

First half 2024 earnings released: EPS: HK$0.65 (vs HK$1.24 in 1H 2023)

Executive Chair of the Board recently bought HK$504k worth of stock

Executive Chair of the Board recently bought HK$334k worth of stock

Upcoming dividend of HK$0.21 per share

First half 2024 earnings released: EPS: HK$0.65 (vs HK$1.24 in 1H 2023)

Hang Lung Group Limited to Report First Half, 2024 Results on Jul 30, 2024

Hang Lung Group Limited Announces Audit Committee Changes, Effective July 1, 2024

Upcoming dividend of HK$0.65 per share

Full year 2023 earnings released: EPS: HK$2.06 (vs HK$2.00 in FY 2022)

Hang Lung Group (HKG:10) Takes On Some Risk With Its Use Of Debt

Executive Vice Chair of the Board recently bought HK$941k worth of stock

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.65

Final dividend of HK$0.65 announced

Full year 2023 earnings released: EPS: HK$2.06 (vs HK$2.00 in FY 2022)

Hang Lung Properties Limited and Hang Lung Group Limited Announce Retirement of Mr. Ronnie Chichung Chan as the Chair, an Executive Director, and the Chair of Executive Committees, with Effect from April 26, 2024

Hang Lung Group Limited Appoints Ms. May Siew Boi Tan as an Independent Non-Executive Director, with Effect from March 20, 2024

Hang Lung Group Limited to Report Fiscal Year 2023 Results on Jan 30, 2024

Investors Continue Waiting On Sidelines For Hang Lung Group Limited (HKG:10)

Hang Lung Group (HKG:10) Takes On Some Risk With Its Use Of Debt

Hang Lung Group (HKG:10) Has Announced A Dividend Of HK$0.21

Upcoming dividend of HK$0.21 per share at 7.8% yield

Hang Lung Group (HKG:10) Is Paying Out A Dividend Of HK$0.21

CEO & Executive Director recently bought HK$542k worth of stock

Hang Lung Group (HKG:10) Will Pay A Dividend Of HK$0.21

First half 2023 earnings released: EPS: HK$1.24 (vs HK$1.06 in 1H 2022)

Hang Lung Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 29 September 2023

Hang Lung Group Limited to Report First Half, 2023 Results on Jul 31, 2023

These 4 Measures Indicate That Hang Lung Group (HKG:10) Is Using Debt Extensively

Upcoming dividend of HK$0.65 per share at 6.3% yield

Full year 2022 earnings released: EPS: HK$2.00 (vs HK$1.90 in FY 2021)

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.65

Hang Lung Group (HKG:10) Is Paying Out A Dividend Of HK$0.65

Hang Lung Group Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 19 May 2023

Full year 2022 earnings released: EPS: HK$2.00 (vs HK$1.90 in FY 2021)

Less than half of directors are independent

Does Hang Lung Group (HKG:10) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: HK$1.06 (vs HK$1.11 in 1H 2021)

Upcoming dividend of HK$0.21 per share

CEO & Executive Director recently bought HK$678k worth of stock

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.21

Hang Lung Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2022, Payable on 29 September 2022

First half 2022 earnings released

Hang Lung Group Limited to Report First Half, 2022 Results on Jul 28, 2022

Calculating The Intrinsic Value Of Hang Lung Group Limited (HKG:10)

Hang Lung Group Limited Approves Final Dividend

Less than half of directors are independent

Does Hang Lung Group (HKG:10) Have A Healthy Balance Sheet?

Now 20% undervalued after recent price drop

Hang Lung Group Limited Proposes Final Dividend for the Year Ended December 31, 2021, Payable on May 19, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hang Lung Group Limited, Annual General Meeting, Apr 27, 2022

Is Hang Lung Group (HKG:10) A Risky Investment?

First half 2021 earnings released: EPS HK$1.11 (vs HK$1.17 loss in 1H 2020)

CEO & Executive Director recently bought HK$2.8m worth of stock

Upcoming dividend of HK$0.21 per share

CFO & Executive Director recently bought HK$562k worth of stock

CFO & Executive Director recently bought HK$417k worth of stock

First half 2021 earnings released: EPS HK$1.11 (vs HK$1.17 loss in 1H 2020)

Calculating The Fair Value Of Hang Lung Group Limited (HKG:10)

Director of General Counsel has left the company

Hang Lung Group Limited Declares Final Dividend for the Year 2020

Upcoming dividend of HK$0.63 per share

Shareholders May Be Wary Of Increasing Hang Lung Group Limited's (HKG:10) CEO Compensation Package

Full year 2020 earnings released: HK$1.13 loss per share (vs HK$5.01 profit in FY 2019)

These 4 Measures Indicate That Hang Lung Group (HKG:10) Is Using Debt Extensively

Are Dividend Investors Making A Mistake With Hang Lung Group Limited (HKG:10)?

Full year 2020 earnings released: HK$1.13 loss per share (vs HK$5.01 profit in FY 2019)

Hang Lung Group Limited, Annual General Meeting, Apr 30, 2021

What Kind Of Investors Own Most Of Hang Lung Group Limited (HKG:10)?

New 90-day high: HK$20.55

Would Shareholders Who Purchased Hang Lung Group's (HKG:10) Stock Three Years Be Happy With The Share price Today?

Hang Lung Group Limited to Report Fiscal Year 2020 Results on Jan 28, 2021

How Much Are Hang Lung Group Limited (HKG:10) Insiders Spending On Buying Shares?